Xu et al. demonstrated glycolysis-associated gemcitabine resistance in BxPC-3 pancreatic cancer cell lines and derived xenografts via the upregulation of HIF1A by HIF1A-AS1 [65]. This evidence concerns the gene HIF1A and pancreatic neoplasm.